Main Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on

Name: Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on
Rating: 5.0 (4 reviews)

Garon, Edward B (author);Ciuleanu, Tudor-Eliade (author);Arrieta, Oscar (author);Prabhash, Kumar (author);Syrigos, Konstantinos N (author);Goksel, Tuncay (author);Park, Keunchil (author);Gorbunova, Vera (author);Kowalyszyn, Ruben Dario (author);Pikiel, Jo

5.0 / 5.0

0 comments

Download Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on book for free from OceanOfPDF

Request Code : ZLIB.IO17903747

Categories:

Year:

2022

Publisher:

Elsevier BV

Language:

English